Home › Stroke › NCT07698522

Digital Technology-Informed Stroke Rehabilitation

Who can join

Ages 30 to 85 · All sexes

Inclusion Criteria:

* Age between 30-85 years.
* Diagnosis of stroke.
* Stroke onset of at least six months prior to the time of participation.
* Fugl Meyer Upper Extremity between 30-50 (mild-moderate)
* Cognitive skills to consent and actively participate, as indicated by scores of ≥ 24 on the Mini- Mental Status Examination
* Able to visit lab up to 5x per week for 3 weeks

Exclusion Criteria:

* Presence of severe aphasia preventing the ability to follow 1-step directions at least 80% of the time.
* Excessive spasticity of the wrist, elbow, and shoulder, defined as a Modified Ashworth Score \>2.
* Diagnosis of neurological disorders other than stroke.
* Orthopedic/musculoskeletal conditions (e.g., severe arthritis) affecting the upper extremity.
* Currently or planning to become pregnant.
* Participation in concurrent occupational therapy.
* Unilateral neglect, defined as failure of the Line Bisection Task
* Upper extremity pain \>= 7/10 on Numeric Rating Scale

About the study

The goal of this study is to determine the effects of lab and home-based technology guidance during movement training post-stroke. The study will compare movement training informed by lab-based technology to training delivered with technology at home. The main questions it aims to answer are:

* How well do lab and home-based technologies help individuals post-stroke improve their movement patterns? * Is there a difference in improvement between the in-lab and at-home training groups? * Which technologies lead to the most improvement?

What is being tested

• Lab-based movement guidance (other)
• Home-based movement guidance (other)

Sponsor: University of Utah · Participants: 60 · Started: Jul 27, 2026

Contact the study team

• Samantha McNeill · Phone: (385) 215-9146‬

Official record on ClinicalTrials.gov — NCT07698522

Locations in the U.S.

Conditions

• Stroke

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.